Abstract:OBJECTIVE:To screen proteomic markers of oral precancerous lesion, local and metastatic squamous cell cancer from human saliva.METHODS:Seventeen patients with oral squamous cell carcinoma, six cases with leukoplakia, seven cases with local metastasis and 15 healthy subjects were selected. All patients were diagnosed of T(1)N(0)M(0) and did not accept any preoperative treatment. Saliva samples were collected preoperatively, combined in the chips (CM-10) for two copies, and tested by surface enhanced laser desorption/ionization (SELDI) mass spectrometry respectively. Chips were detected by the PBS-II plus mass spectrometer reader. Mass accuracy was calibrated by the all-in-one peptide molecular mass standard (ciphergen ciosystems).RESULTS:The differentiated pattern between oral squamous cell carcinoma and healthy people consisted of four biomarker peaks of 5797, 2902, 3883, 4951 (mass/charge) with the sensitivity of 88.24% and specificity of 93.33%. The differentiated pattern between oral squamous cell carcinoma and leukoplakia consisted of three biomarker peaks of 5818, 4617 and 3884 with the sensitivity of 100.00% and specificity of 100.00%. The differentiated pattern between oral squamous cell carcinoma and oral cancer with local metastatic consisted of three biomarker peaks of 55 809 and 5383 (mass/charge) with the sensitivity of 94.12% and specificity of 85.71%.CONCLUSIONS:The biomarkers selected by SELDI could help in the adjuvant early diagnosis of oral cancer and forecasting the transformation from leukoplakia to oral cancer and metastasis.

Reagent kit for diagnosing oral squamous cell carcinoma

Proteomic Diagnosis Models from Serum for Early Detection of Oral Squamous Cell Carcinoma.

[Application of Saliva Protein Fingerprints in the Diagnosis of Oral Squamous Cell Cancer by Surface Enhanced Laser Desorption Ionization Time of Flight Mass].

Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.

Discovery of specific ligands for oral squamous carcinoma to develop anti-cancer drug loaded precise targeting nanotherapeutics.

Human colorectal cancer protein mark CLCA1 (calcium-activated chloride channel 1) kit and application thereof

Selection and Quantitative Detection of Target Genes in Oral Squamous Cell Carcinoma

Kit for predicting lung adenocarcinoma progression, prognosis and drug resistance of lung-adenocarcinoma patients using HOXB13 combined with HOXB13 downstream target gene detection

Kit used for detecting nasopharyngeal carcinoma and application thereof

Product for detecting RBP1 gene or protein and application

Identification of Biomarkers Related to Regulatory T Cell Infiltration in Oral Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.

Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma

Identification of differentially expressed genes in oral squamous cell carcinoma TCA8113 cells.

Detection primer and probe for nasopharynx cancer marker as well as application thereof

Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer

Cathepsin D antigen polypeptide and application thereof as well as detecting kit containing polypeptide

Proteomics-based Identification of Haptoglobin As a Novel Plasma Biomarker in Oral Squamous Cell Carcinoma

Quantitative Proteomic Analysis of Microdissected Oral Epithelium for Cancer Biomarker Discovery

Primers and kit for detecting specific gene HB-1 of acute B lymphocyte leukemia

Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets

Composition for detecting chemoradiotherapy sensitivity of rectal cancers, micro array and computer system